Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vinpocetine in Parkinson's Disease
NCT07229664Phase 3Recruiting
- Sponsor
- Tanta University
- Start
- Nov 2025
- Primary completion
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of vinpocetine in Parkinson's disease (PD), sponsored by Tanta University. Started Nov 2025; status: recruiting.
02
Drugs
vinpocetine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT07229664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07229664.